Department of Medicine
Faculty Profiles by Division

Department of Medicine

Faculty Profiles

[Return To Index page]
photo Jaideep Behari, MD, PhD

Gastroenterology

Associate Professor of Medicine

Director, FLOW Clinic (Fatty Liver, Obesity, and Wellness Clinic)

Associate Director, Pittsburgh Liver Research Center (PLRC)

Email: jab31@pitt.edu

Phone: 412-647-4526

Contact
Office: Division of Gastroenterology, Hepatology & Nutrition Center for Liver Diseases
3471 Fifth Ave 900 Kaufmann Bldg
Pittsburgh, PA 15213
 
Phone: 412-647-4526
Fax: 412-647-9268
E-mail: jab31@pitt.edu
Administrative Assistant:
Roxann Huemme-Academic
Address: UPMC Center for Liver Diseases & FLOW Center
Kaufmann Building
Pittsburgh, PA 15213
Phone: 412-647-7922
Fax: 412-647-9268
Administrative Assistant:
Clinical-Procedure Scheduling
Address: UPMC Center for Liver Diseases & FLOW Center
Kaufmann Building & Digestive Disorders Center
Pittsburgh, PA 15213
Phone: 412-647-4526
Fax: 412-647-9268
Education and Training
Education
MBBS, University of Rajasthan, 1993
PhD, University of Georgia, 1998
Training
Internal Medicine Residency, University of Massachusetts, 2002
Internal Medicine Residency, University of Pittsburgh, 2003
Fellowship, Gastroenterology/Hepatology, University of Pittsburgh, 2006
Research Fellowship, Massachusetts General Hospital/ Harvard Medical School, 2000
Research Interest
Dr. Behari is an Associate Professor whose research investigates the role of intracellular signaling pathways in the pathogenesis of liver diseases. He is also interested in nonalcoholic fatty liver disease, alcoholic fatty liver disease and hepatocellular carcinoma.
Clinical Interest
Dr. Behari is a hepatologist with a subspecialty interest in non-alcoholic fatty liver disease (NAFLD).
Publications
For my complete bibliography, Click Here.
Selected Publications:
Behari, J., Yeh, T.H., Krauland, L., Otruba, W., Cieply, B., Hauth, B., Apte, U., Wu, T., Evans, R., Monga, S.P. Liver-specific beta-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitis. American Journal of Pathology. 2010; 176(2): 744-53.
Yeh, T.H., Krauland, L., Singh, V., Zou, B., Devaraj, P., Stolz, D.B., Franks, J., Monga, S.P., Sasatomi, E., Behari, J. Liver-specific B-Catenin Knockout Mice Have Bile Canalicular Abnormalities, Bile Secretory Defect and Intrahepatic Cholestasis. Hepatology. 2010; 52(4): 1410-9.
Liu, S., Yeh, T.H., Singh, V.P., Shiva, S., Krauland, L., Li, H., Zhang, P., Kharbanda, K., Ritov, V., Monga, S.P., Scott, D.K., Eagon, P.K., Behari, J. B-catenin is essential for ethanol metabolism and protection against alcohol-mediated liver steatosis in mice. Hepatology. 2012; 55(3): 931-40.
Ganesh, S., Rogal, S.S., Yadav, D., Humar, A., Behari, J. Risk Factors for Frequent Readmissions and Barriers to Transplantation in Patients with Cirrhosis. PLoS One. 2013; 8(1): e55140.
Rachakonda, V., Gabbert, C., Raina, A., Li, H., Malik, S., DeLany, J.P., Behari, J. Stratification of Risk of Death in Severe Acute Alcoholic Hepatitis Using a Panel of Adipokines and Cytokines. Alcoholism: Clinical and Experimental Research. 2014; 38(11): 2712-21.
Dudekula, A., Rachakonda, V., Shaik, B., Behari, J. Weight Loss in Nonalcoholic Fatty Liver Disease Patients in an Ambulatory Care Setting is Largely Unsuccessful but Correlates with Frequency of Clinic Visits. PLoS One. 2014; 9(11): e111808.
Behari, J., Li, H., Liu, S., Stefanovic-Racic, M., Alonso, L., O'Donnell, C.P., Shiva, S., Singamsetty, S., Watanabe, Y., Singh, V.P., Liu, Q. B-Catenin Links Hepatic Metabolic Zonation with Lipid Metabolism and Diet-induced Obesity in Mice. American Journal of Pathology. 2014; 184(12): 3284-98.
Rachakonda, V., Gabbert, C., Rain, A., Bell, L.N., Cooper, S., Malik, S., Behari, J. Serum metabolomic profiling in acute alcoholic hepatitis identifies multiple dysregulated pathways. PLoS One. 2014; 9(12): e113860.
Behari, J., Sylvester, K.G. Role of the Wnt/B-catenin pathway in the pathogenesis of alcoholic liver disease. Current Molecular Pharmacology. 2015.
Rachakonda, V., Borhani, A.A., Dunn, M.A., Andrzejewski, M., Martin, K., Behari, J. Serum leptin is a biomarker of malnutrition in decompensated cirrhosis. PLoS One. 2016.
Sponsored Research/Activities
Title: Combining Obesity, NAFLD and Diabetes Management Through Integrated Treatment Pathways (CONDUIT)
Role: Principal Investigator
Funding Agency: Gilead Sciences, Inc.
Grant Number: RES
Start Year: 2020
End Year: 2022
Title: The IMAGES Study: Imaging-based Assessment of Grade of Steatosis in NAFLD
Role: Principal Investigator
Funding Agency: Endra Life Sciences
Grant Number: RES
Start Year: 2019
End Year: 2020
Title: A VACULARIZED PATIENT-DERIVED Ipsc LIVER ACINUS MICROPHYSIOLOGY SYSTEM AS AN INNOVATIVE PRECISION
Role: Co-Investigator
Funding Agency: National Institute of Health
Grant Number: UG3 TROO3289
Start Year: 2020
End Year: 2022
Title: Non-Alcoholic Steatohepatitis (NASH) Prevalence Estimation and Risk Stratification using a Multi-System Regional Research Network Database
Role: Co-Investigator
Funding Agency: Pfizer Inc.
Grant Number: RES
Start Year: 2019
End Year: 2021
Title: Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies (Collaborative U01)
Role: Co-Investigator
Funding Agency: National Institute on Alcohol Abuse & Alcoholism
Grant Number: U01 AA026978
Start Year: 2018
End Year: 2023
Title: Alcohol Bio-Sensor Monitoring for Patients with Alcoholic Liver Disease
Role: Co-Investigator
Funding Agency: National Institute on Alcohol Abuse & Alcoholism
Grant Number: R21 AA025730
Start Year: 2018
End Year: 2020
Notable Achievements
Poster of Distinction, 56th Annual Meeting of AASLD, 2005
Ruth L. Kirschstein National Research Service Award, 2004-2006